CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. The company leverages integrated analytical platforms in immunology, histopathology, proteomics, and genomics, along with related specimen collection and logistics services, to support the entire drug development cycle, from discovery to late-stage clinical trials. With a global presence, CellCarta operates facilities in Canada, the USA, Belgium, Australia, and China. The organization is dedicated to making a positive impact on human health and well-being, working with a team of professionals committed to advancing patient therapy.